U.S. markets close in 6 hours 14 minutes

Arena Pharmaceuticals, Inc. (ARNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.91+0.52 (+0.80%)
As of 9:45AM EST. Market open.

Arena Pharmaceuticals, Inc.

6154 Nancy Ridge Drive
San Diego, CA 92121
United States
858 453 7200
http://www.arenapharm.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees320

Key Executives

NameTitlePayExercisedYear Born
Mr. Amit D. Munshi M.B.A.Pres, CEO & Director1.23MN/A1968
Mr. Vincent E. AurentzExec. VP & Chief Bus. Officer701.81k1.66M1968
Dr. Preston S. KlassenAdvisor791.36k512.14k1969
Mr. Robert LisickiExec. VP & Chief Commercial Officer841.77kN/A1967
Ms. Laurie D. StelzerExec. VP & CFON/AN/A1968
Dr. Douglas A. BakanExec. VP of Technical OperationsN/AN/AN/A
Megan E. KnightDirector of Investor RelationsN/AN/AN/A
Ms. Joan SchmidtExec. VP, Gen. Counsel & Sec.N/AN/A1964
Ms. Suzanne C. ZoumarasExec. VP & Chief HR OfficerN/AN/A1964
Mr. Steven W. SpectorConsultantN/AN/A1965
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, a Phase IIb/III clinical trial for Crohn's disease, and a Phase IIb clinical trial for atopic dermatitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; and APD418 that is in Phase I clinical trial for acute heart failure. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Corporate Governance

Arena Pharmaceuticals, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.